Parallel Advisors, LLC Genfit S.A. Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$3.67 - $5.59 $436 - $665	-119 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$5.2 - $22.0 $2,496 - $10,560	-480 Reduced 80.13%	119 $0
Q1 2020 Apr 27, 2020	BUY	$10.95 - $20.76 $4,117 - $7,805	376 Added 168.61%	599 $8,000
Q4 2019 Jan 30, 2020	BUY	$13.55 - $20.14 $3,021 - $4,491	223 New	223 $4,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.